Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry.
about
Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS.Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer.Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolismThe effect of Echinacea purpurea on the pharmacokinetics of docetaxel.Quantification of taxanes in biological matrices: a review of bioanalytical assays and recommendations for development of new assays.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor.Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation.Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.From mouse to man: predictions of human pharmacokinetics of orally administered docetaxel from preclinical studies.Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry.Quantification of Paclitaxel and Polyaspartate Paclitaxel Conjugate in Beagle Plasma: Application to a Pharmacokinetic Study.Lessons learned from development of docetaxel
P2860
Q31136016-F6917151-FFCB-4922-A205-0AED5CEEBDDAQ33795052-40DD625A-FCEC-4CB5-B462-B78B48F6C0A5Q36099442-78ED789E-67DA-41B2-A827-661DBD16F90EQ37161914-5BAB3E3A-2095-4B43-89A1-78C4BAB804A1Q38210103-475E012B-9AEF-48E1-A779-C77C568EAFE5Q38568180-4984B5DB-F261-42A0-9BB0-EFAB49546BC4Q38976808-8028A4F0-5830-4B47-9163-9040D88F8CE7Q40036535-10E1CE4A-A3FD-491C-B09F-C9EEF1AE45A1Q41187621-73D112F6-EDB6-4DD0-9BBC-089AEACC3FFFQ45162147-67A06C95-0689-4B9B-93BF-1C988EA493C4Q48935667-E04E12B7-A57B-46DC-B1DF-B1A84BC80717Q51307074-B28E933D-8941-4141-9B37-29C84FC3F739Q58382477-A4C989C9-3F65-4D1A-82C8-D062F6138113
P2860
Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Quantitative analysis of docet ...... with tandem mass spectrometry.
@ast
Quantitative analysis of docet ...... with tandem mass spectrometry.
@en
type
label
Quantitative analysis of docet ...... with tandem mass spectrometry.
@ast
Quantitative analysis of docet ...... with tandem mass spectrometry.
@en
prefLabel
Quantitative analysis of docet ...... with tandem mass spectrometry.
@ast
Quantitative analysis of docet ...... with tandem mass spectrometry.
@en
P2093
P356
P1476
Quantitative analysis of docet ...... with tandem mass spectrometry.
@en
P2093
I E L M Kuppens
J H Beijnen
J H M Schellens
M J van Maanen
P304
P356
10.1002/BMC.457
P577
2005-06-01T00:00:00Z